Related references
Note: Only part of the references are listed.Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56
Katharina Kriegsmann et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections
Sanjay Mukhopadhyay et al.
MODERN PATHOLOGY (2019)
Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts
Ivan Gonzalez et al.
HISTOPATHOLOGY (2019)
A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases
Cem Leblebici et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2019)
Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears
Tripti Nakra et al.
CANCER CYTOPATHOLOGY (2019)
Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience
Erika F. Rodriguez et al.
HUMAN PATHOLOGY (2019)
Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma)
Patrick S. Rush et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor
Masahiko Tanigawa et al.
MEDICAL MOLECULAR MORPHOLOGY (2018)
Insulinoma-Associated Protein 1 Immunostain: A Diagnostic Tool for Pulmonary Small Cell Carcinoma in Cytology
Erika F. Rodriguez et al.
ACTA CYTOLOGICA (2018)
Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens
Erika E. Doxtader et al.
CANCER CYTOPATHOLOGY (2018)
Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate
Zhixiang Xin et al.
HUMAN PATHOLOGY (2018)
INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma
Mohammed T. Lilo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity
Lisa M. Rooper et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
INSM1A A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms
Jason N. Rosenbaum et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Reliability of Immunostaining Using Pan-Melanoma Cocktail, SOX10, and Microphthalmia Transcription Factor in Confirming a Diagnosis of Melanoma on Fine-Needle Aspiration Smears
Jessica Clevenger et al.
CANCER CYTOPATHOLOGY (2014)
Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens
Lichao Zhao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Validation of commonly used immunostains on cell-transferred cytologic specimens
Y Gong et al.
CANCER CYTOPATHOLOGY (2005)
Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma
Y Gong et al.
CANCER CYTOPATHOLOGY (2004)
Share Paper
